📣 VC round data is live. Check it out!
- Public Comps
- Kenvue
Kenvue Valuation Multiples
Discover revenue and EBITDA valuation multiples for Kenvue and similar public comparables like Henkel, Estee Lauder, Reckitt, Haleon and more.
Kenvue Overview
About Kenvue
Kenvue is the world’s largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson’s consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women’s health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson’s, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.
Founded
2022
HQ

Employees
22.0K
Website
Sectors
Financials (LTM)
EV
$41B
Valuation Multiples
Start free trialKenvue Financials
Kenvue reported last 12-month revenue of $15B and EBITDA of $4B.
In the same LTM period, Kenvue generated $9B in gross profit, $4B in EBITDA, and $2B in net income.
Revenue (LTM)
Kenvue P&L
In the most recent fiscal year, Kenvue reported revenue of $15B and EBITDA of $3B.
Kenvue is profitable as of last fiscal year, with gross margin of 58%, EBITDA margin of 23%, and net margin of 14%.
Financial data powered by Morningstar, Inc.
Kenvue Stock Performance
Kenvue has current market cap of $33B, and enterprise value of $41B.
Market Cap Evolution
Kenvue's stock price is $17.15.
Kenvue share price decreased by 2.2% in the last 30 days, and by 28.2% in the last year.
Kenvue has an EPS (earnings per share) of $1.08.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $41B | $33B | -0.2% | -2.2% | -10.3% | -28.2% | $1.08 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialKenvue Valuation Multiples
Kenvue trades at 2.7x EV/Revenue multiple, and 11.4x EV/EBITDA.
EV / Revenue (LTM)
Kenvue Financial Valuation Multiples
As of May 20, 2026, Kenvue has market cap of $33B and EV of $41B.
Kenvue has a P/E ratio of 15.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Kenvue Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Kenvue Margins & Growth Rates
Kenvue grew revenue by 3% and EBITDA by 11% in the last fiscal year.
In the most recent fiscal year, Kenvue reported gross margin of 58%, EBITDA margin of 23%, and net margin of 14%.
Kenvue Margins
Kenvue Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Kenvue Operational KPIs
Kenvue's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.3M for the same period.
Kenvue's Rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Kenvue's Rule of X is 33% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Kenvue Competitors
Kenvue competitors include Henkel, Estee Lauder, Reckitt, Haleon, Church & Dwight, Bayer, Ulta Beauty, Galderma, Essity and Beiersdorf.
Most Kenvue public comparables operate across Health & Beauty.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.3x | 1.3x | 7.1x | 7.1x | |||
| 2.4x | 2.3x | 17.1x | 14.0x | |||
| 2.5x | 2.7x | 7.6x | 9.1x | |||
| 3.3x | 3.3x | 12.9x | 12.6x | |||
| 3.9x | 3.9x | 17.2x | 17.0x | |||
| 1.4x | 1.4x | 6.8x | 6.9x | |||
| 1.8x | 1.8x | 12.3x | 12.1x | |||
| 9.2x | 8.6x | 39.9x | 35.3x | |||
This data is available for Pro users. Sign up to see all Kenvue competitors and their valuation data. Start Free Trial | ||||||
Kenvue Funding History
Before going public, Kenvue raised $4B in total equity funding, across 1 round.
Kenvue Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Kenvue
| When was Kenvue founded? | Kenvue was founded in 2022. |
| Where is Kenvue headquartered? | Kenvue is headquartered in United States. |
| How many employees does Kenvue have? | As of today, Kenvue has over 22K employees. |
| Who is the CEO of Kenvue? | Kenvue's CEO is Kirk L. Perry. |
| Is Kenvue publicly listed? | Yes, Kenvue is a public company listed on NYSE. |
| What is the stock symbol of Kenvue? | Kenvue trades under KVUE ticker. |
| When did Kenvue go public? | Kenvue went public in 2023. |
| Who are competitors of Kenvue? | Kenvue main competitors include Henkel, Estee Lauder, Reckitt, Haleon, Church & Dwight, Bayer, Ulta Beauty, Galderma, Essity, Beiersdorf. |
| What is the current market cap of Kenvue? | Kenvue's current market cap is $33B. |
| What is the current revenue of Kenvue? | Kenvue's last 12 months revenue is $15B. |
| What is the current revenue growth of Kenvue? | Kenvue revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Kenvue? | Current revenue multiple of Kenvue is 2.7x. |
| Is Kenvue profitable? | Yes, Kenvue is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Kenvue? | Kenvue's last 12 months EBITDA is $4B. |
| What is Kenvue's EBITDA margin? | Kenvue's last 12 months EBITDA margin is 23%. |
| What is the current EV/EBITDA multiple of Kenvue? | Current EBITDA multiple of Kenvue is 11.4x. |
| What is the current FCF of Kenvue? | Kenvue's last 12 months FCF is $2B. |
| What is Kenvue's FCF margin? | Kenvue's last 12 months FCF margin is 13%. |
| What is the current EV/FCF multiple of Kenvue? | Current FCF multiple of Kenvue is 19.8x. |
| How many companies Kenvue has acquired to date? | Kenvue hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Kenvue has invested to date? | Kenvue hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Kenvue
Lists including Kenvue
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.